Avelumab in Patients With Metastatic Colorectal Cancer.

Jason M Redman,Geraldine O'Sullivan Coyne,Clay T Reed,Ravi A Madan,Julius Strauss,Seth J Steinberg,Jennifer Marté,Lisa Cordes,Christopher Heery,James L Gulley

The oncologist（2023）

引用 0|浏览11

暂无评分

摘要

As demonstrated with other anti-PD-1/PD-L1 monoclonal antibodies, avelumab is not active in unselected patients with mCRC (ClinicalTrials.gov Identifier: NCT01772004).

查看译文

关键词

colon cancer, avelumab, immune checkpoint inhibitors, clinical trials, immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要